Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$57.1M |
| 2 |
Veralto
VLTO
|
+$54.6M |
| 3 |
Newmont
NEM
|
+$40.4M |
| 4 |
Vertiv
VRT
|
+$17.2M |
| 5 |
Webster Financial
WBS
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$314M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$237M |
| 3 |
Microsoft
MSFT
|
+$231M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.88% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.38% |
| 5 | Communication Services | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PTC Therapeutics
PTCT
$5.97B
| $3.68M | ﹤0.01% |
133,565
-13,200
| -9% | -$302K |
|
|
CBAY
1477
DELISTED
Cymabay Therapeutics
CBAY
| $3.67M | ﹤0.01% |
155,400
-26,100
| -14% | -$465K |
|
1478
WesBanco
WSBC
$4.12B
| $3.67M | ﹤0.01% |
116,945
-13,300
| -10% | -$357K |
|
|
GRP.U
1479
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3.66M | ﹤0.01% |
63,500
-5,400
| -8% | -$280K |
|
1480
Sylvamo
SLVM
$1.55B
| $3.65M | ﹤0.01% |
74,300
-10,000
| -12% | -$467K |
|
1481
Andersons Inc
ANDE
$2.23B
| $3.64M | ﹤0.01% |
63,250
-7,200
| -10% | -$374K |
|
1482
RLJ Lodging Trust
RLJ
$1.68B
| $3.64M | ﹤0.01% |
310,358
-39,500
| -11% | -$410K |
|
|
VSXY
1483
Victoria's Secret
VSXY
$7.15B
| $3.64M | ﹤0.01% |
137,000
-16,500
| -11% | -$350K |
|
1484
Lumen
LUMN
$6.78B
| $3.64M | ﹤0.01% |
1,986,500
-221,000
| -10% | -$313K |
|
1485
Banner Corp
BANR
$2.51B
| $3.63M | ﹤0.01% |
67,700
-7,800
| -10% | -$359K |
|
1486
Telephone and Data Systems
TDS
$4.06B
| $3.62M | ﹤0.01% |
197,100
-22,500
| -10% | -$415K |
|
|
DQ
1487
Daqo New Energy
DQ
$1.02B
| $3.61M | ﹤0.01% |
135,712
| – | – |
|
1488
Laureate Education
LAUR
$5.18B
| $3.61M | ﹤0.01% |
263,300
-30,400
| -10% | -$417K |
|
1489
Beam Therapeutics
BEAM
$2.68B
| $3.61M | ﹤0.01% |
132,600
-9,800
| -7% | -$243K |
|
1490
MaxLinear
MXL
$7.34B
| $3.61M | ﹤0.01% |
151,673
-15,400
| -9% | -$302K |
|
1491
Iovance Biotherapeutics
IOVA
$2.9B
| $3.57M | ﹤0.01% |
439,456
-49,900
| -10% | -$261K |
|
1492
Virtu Financial
VIRT
$5.05B
| $3.57M | ﹤0.01% |
176,100
-23,200
| -12% | -$428K |
|
1493
Central Garden & Pet Co Class A
CENTA
$2.41B
| $3.56M | ﹤0.01% |
101,000
-12,500
| -11% | -$401K |
|
1494
Upwork
UPWK
$1.06B
| $3.56M | ﹤0.01% |
239,300
-24,800
| -9% | -$320K |
|
|
DVAX
1495
DELISTED
Dynavax Technologies
DVAX
| $3.55M | ﹤0.01% |
253,878
-28,500
| -10% | -$396K |
|
1496
Hillman Solutions
HLMN
$1.7B
| $3.54M | ﹤0.01% |
383,900
-43,700
| -10% | -$333K |
|
1497
Mirion Technologies
MIR
$3.95B
| $3.52M | ﹤0.01% |
343,600
-39,600
| -10% | -$334K |
|
1498
Federal Agricultural Mortgage
AGM
$2.52B
| $3.51M | ﹤0.01% |
18,381
-2,100
| -10% | -$342K |
|
|
SIX
1499
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.51M | ﹤0.01% |
139,900
-15,700
| -10% | -$362K |
|
1500
Triumph Financial Inc
TFIN
$1.88B
| $3.5M | ﹤0.01% |
43,600
-5,200
| -11% | -$352K |
|
Similar funds
Swiss National Bank's Q4 2023 Portfolio in Review
As of Q4 2023, Swiss National Bank held 2,646 positions worth $136B, up 6.9% from $127B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $4.96B in Q4 2023, closing 112 positions and reducing 2,341 holdings. Its most notable exit was Activision Blizzard, an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Veralto worth $60.2M.
- Swiss National Bank's largest Q4 2023 buy was Veralto: 731,669 shares worth $60.2M.
- Swiss National Bank added most to Broadcom in Q4 2023, an estimated $57.1M increase.
- Swiss National Bank's biggest Q4 2023 reduction was Apple, cutting an estimated $314M.
- Swiss National Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $237M.
- Swiss National Bank's ten largest holdings make up 28% of its $136B portfolio in Q4 2023.
- Swiss National Bank opened 38 new positions and closed 112 in Q4 2023.
- Swiss National Bank's portfolio value rose 6.9% quarter-over-quarter to $136B.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.